Pre-exposure prophylaxis to prevent HIV among MSM in Europe
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
Interventions to prevent HIV and hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness
MacArthur, G.J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V., Taylor, A., Roy, K., Aspinall, E., Goldberg, D., Rhodes, T., Hedrich, D., Salminen, M., Hickman, M., Hutchinson, S.J.
Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Eurosurveillance, Volume 24, Issue 41, 10 Oct 2019
The efficacy of PrEP is well-documented [1-3]. Research in New South Wales, Australia, indicates that population-level impact of PrEP on HIV can be achieved among men who have sex with men (MSM) with a targeted, accessible programme. The article describes the progress made by countries in Europe and Central Asia (the 53 countries of the WHO European Region plus Kosovo* and Liechtenstein) in implementing PrEP and estimates the gap between PrEP access and expressed need at country and at EU level.
Around half a million men who have sex with men in the EU need PrEP but cannot access it
This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.